Yishu Wang

1.8k total citations · 2 hit papers
49 papers, 1.1k citations indexed

About

Yishu Wang is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Yishu Wang has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Yishu Wang's work include Cancer, Hypoxia, and Metabolism (6 papers), Chronic Kidney Disease and Diabetes (5 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Yishu Wang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Chronic Kidney Disease and Diabetes (5 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Yishu Wang collaborates with scholars based in China, United States and Sweden. Yishu Wang's co-authors include Honglan Zhou, Zhi‐Xiang Xu, Yong‐Ping Jian, Yanghe Zhang, Yuning Zhang, Dan Zhang, Yao Li, Hui-Hui Sun, Qingfei Meng and Bin Liu and has published in prestigious journals such as PLoS ONE, Journal of Applied Physics and Water Research.

In The Last Decade

Yishu Wang

46 papers receiving 1.1k citations

Hit Papers

Short-chain fatty acids in diseases 2023 2026 2024 2025 2023 2024 100 200 300

Peers

Yishu Wang
Anthony R. Cyr United States
Dan Huang China
Jie Hao China
Rui Yu China
Anthony R. Cyr United States
Yishu Wang
Citations per year, relative to Yishu Wang Yishu Wang (= 1×) peers Anthony R. Cyr

Countries citing papers authored by Yishu Wang

Since Specialization
Citations

This map shows the geographic impact of Yishu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yishu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yishu Wang more than expected).

Fields of papers citing papers by Yishu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yishu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yishu Wang. The network helps show where Yishu Wang may publish in the future.

Co-authorship network of co-authors of Yishu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yishu Wang. A scholar is included among the top collaborators of Yishu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yishu Wang. Yishu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Hongxia, Dan Zhang, Zehua Zhang, et al.. (2025). Omega-3 polyunsaturated fatty acids alleviate renal fibrosis in chronic kidney disease by reducing macrophage activation and infiltration through the JAG1-NOTCH1/2 pathway. International Immunopharmacology. 152. 114454–114454. 3 indexed citations
2.
Wang, Yishu, Yanhui Hao, Chen-Chi Duan, et al.. (2025). Antenatal depressive and anxiety symptoms in early pregnancy and offspring allergic diseases during toddlerhood. World Journal of Pediatrics. 21(5). 478–488. 1 indexed citations
3.
Zhang, Chang, Qingfei Meng, Huixin Liu, et al.. (2025). Lactylation in cancer: Metabolic-epigenetic nexus and therapeutic frontiers. Critical Reviews in Oncology/Hematology. 217. 105034–105034.
4.
Zhang, Dan, Bin Liu, Hongxia Yang, et al.. (2025). Activation of TLR4-NF-κB signaling in renal tubular epithelial cells facilitates renal allograft fibrosis by inhibiting peroxisome biogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1872(2). 168066–168066.
5.
Wang, Yu-Xiong, Bin Liu, Yanghe Zhang, et al.. (2024). Unveiling the enigmatic role of MYH9 in tumor biology: a comprehensive review. Cell Communication and Signaling. 22(1). 417–417. 6 indexed citations
7.
Zhou, Fangyue, Yishu Wang, Yujie Niu, et al.. (2024). Associations between maternal early pregnancy depression and longitudinal fetal growth. Journal of Affective Disorders. 362. 808–815. 1 indexed citations
8.
Zhao, Xiaodong, et al.. (2024). Role of mitochondria in pathogenesis and therapy of renal fibrosis. Metabolism. 155. 155913–155913. 25 indexed citations
9.
Xiong, Ying, et al.. (2024). Integrating the symptom experience and coping in patients with stage I-III breast cancer in China: A qualitative study. European Journal of Oncology Nursing. 73. 102692–102692. 4 indexed citations
10.
Wu, Hao, Yishu Wang, Haiyang Zhang, et al.. (2024). Association between cathepsins and benign prostate diseases: a bidirectional two-sample Mendelian randomization study. Frontiers in Endocrinology. 15. 1348310–1348310.
11.
Pan, Yujie, Xiaodong Zhao, Faping Li, et al.. (2023). Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression. Clinical Nutrition. 43(2). 332–345. 47 indexed citations
12.
Wang, Yu-Xiong, Bin Liu, Faping Li, et al.. (2023). The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma. Frontiers in Endocrinology. 14. 1274239–1274239. 9 indexed citations
13.
Zhang, Dan, Yong‐Ping Jian, Yuning Zhang, et al.. (2023). Short-chain fatty acids in diseases. Cell Communication and Signaling. 21(1). 212–212. 320 indexed citations breakdown →
14.
Wang, Yu-Xiong, et al.. (2023). Regulatory mechanisms of the cAMP-responsive element binding protein 3 (CREB3) family in cancers. Biomedicine & Pharmacotherapy. 166. 115335–115335. 15 indexed citations
15.
Meng, Qingfei, Huihui Sun, Yao Li, et al.. (2022). The role of transketolase in human cancer progression and therapy. Biomedicine & Pharmacotherapy. 154. 113607–113607. 33 indexed citations
16.
Li, Faping, Hui Guo, Nian Liu, et al.. (2020). Explore prognostic biomarker of bladder cancer based on competing endogenous network. Bioscience Reports. 40(12). 7 indexed citations
17.
Shen, Xiangfeng, Yuan Zhao, Guolong Liu, et al.. (2020). Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer. Life Sciences. 256. 117923–117923. 28 indexed citations
18.
Wang, Yishu, Lei Pang, Yanghe Zhang, Jiahui Lin, & Honglan Zhou. (2019). Fenofibrate Improved Interstitial Fibrosis of Renal Allograft through Inhibited Epithelial-Mesenchymal Transition Induced by Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2019. 1–12. 26 indexed citations
19.
Xin, Ying, Xin Jiang, Yishu Wang, et al.. (2016). Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia. PLoS ONE. 11(1). e0145838–e0145838. 58 indexed citations
20.
Wang, Yishu, et al.. (2012). Isolation and characterization of cancer stem cells from cervical cancer HeLa cells. Cytotechnology. 64(4). 477–484. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026